Seattle-based biotech Vedana Therapeutics launched out of stealth Wednesday with a $46 million Series A round.
The $14 million initiative at Soaring Heights Communities includes modernizing utilities and housing interiors for 3,100 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results